BillionToOne to Participate in Two Upcoming Investor Conferences

MENLO PARK, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that the Company will participate in two upcoming investor conferences. * UBS Global Healthcare Conference 2026 Fireside Chat on Tuesday, November 10(th) at 2:00 PM ET * Stifel 2026 Healthcare Conference Fireside Chat on Wednesday, November 11(th) at 3:20 PM ET A live and archived webcast of the events will be available on the “Events” page of BillionToOne’s investor relations website at https://investors.billiontoone.com/.

Headquartered in Menlo Park, California, BillionToOne is a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all. The company's patented Quantitative Counting Templates™ (QCT™) molecular counting platform is the only multiplex technology that can accurately count DNA molecules at the single-molecule level. For more information, visit www.billiontoone.com.